Showing results (1781-1790 of 1,799) with videos related to

Sort By:
Pageof 180
The Lancet. Oncology|June 28, 2015
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trialAntoni Ribas, Igor Puzanov, Reinhard Dummer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2022
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)Jeffrey S Weber, Dirk Schadendorf, Michele Del Vecchio, et al.
ACS Medicinal Chemistry Letters|August 16, 2023
Discovery of MK-8768, a Potent and Selective mGluR2 Negative Allosteric ModulatorMichael T Rudd, Peter J Manley, Barbara Hanney, et al.
Angewandte Chemie (International Ed. in English)|June 30, 2016
Discovery of a Highly Selective Glycogen Synthase Kinase-3 Inhibitor (PF-04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET NeuroimagingSteven H Liang, Jinshan Michael Chen, Marc D Normandin, et al.
Genome Research|June 8, 2017
Comprehensive global genome dynamics of <i>Chlamydia trachomatis</i> show ancient diversification followed by contemporary mixing and recent lineage expansionJames Hadfield, Simon R Harris, Helena M B Seth-Smith, et al.
Thyroid : Official Journal of the American Thyroid Association|January 8, 2020
A Thyroid Genetic Classifier Correctly Predicts Benign Nodules with Indeterminate Cytology: Two Independent, Multicenter, Prospective Validation TrialsMark Zafereo, Bryan McIver, Sergio Vargas-Salas, et al.
Cancer Cell|December 12, 2025
Multi-omic landscape of human gliomas from diagnosis to treatment and recurrenceHadeesha Piyadasa, Benjamin Oberlton, Mikaela Ribi, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Multi-omic landscape of human gliomas from diagnosis to treatment and recurrenceHadeesha Piyadasa, Benjamin Oberlton, Mikaela Ribi, et al.
Nature Genetics|November 7, 2006
Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversibleBernward Hinkes, Roger C Wiggins, Rasheed Gbadegesin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2022
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort studyCarl-Jacob Holmberg, Lars Ny, Tina J Hieken, et al.
Pageof 180